Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 433814011000036116 | Bordetella pertussis, acellular pertactin vaccine 2.5 microgram + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + diphtheria toxoid vaccine 2 international units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units + tetanus toxoid vaccine 20 international units injection, 10 x 0.5 mL syringes (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 433816011000036112 | diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 10 x 0.5 mL syringes | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 10 x 0.5 mL syringes | Is a | diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram injection, 10 x 0.5 mL syringes | false | Inferred relationship | Some | ||
| diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 10 x 0.5 mL syringes | Is a | poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 10 x 0.5 mL syringes | false | Inferred relationship | Some | ||
| diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 10 x 0.5 mL syringes | has MPUU | diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL syringe | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Boostrix-IPV injection suspension, 10 x 0.5 mL syringes | Is a | False | diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 10 x 0.5 mL syringes | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR